Biochemical aspects in autism spectrum disorders: updating the opioid-excess theory and presenting new opportunities for biomedical intervention

Author： Whiteley Paul   Shattock Paul  

Publisher： Informa Healthcare

ISSN： 1472-8222

Source： Expert Opinion on Therapeutic Targets, Vol.6, Iss.2, 2002-04, pp. : 175-183

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Melatonin in Autism Spectrum Disorders

By  

Current Clinical Pharmacology, Vol. 9, Iss. 4, 2014-11 ,pp. : 326-334

Bentham Science Publishers

Access to resources Recommend Favorite

New directions in the treatment of autism spectrum disorders from animal model research

By Chadman Kathryn K   Guariglia Sara R   Yoo Jiyeon Helen  

Expert Opinion on Drug Discovery, Vol. 7, Iss. 5, 2012-05 ,pp. : 407-416

Informa Healthcare

Access to resources Recommend Favorite

Editorial (Thematic Issue: New Therapeutic Targets for Autism Spectrum Disorders)

By  

CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders), Vol. 15, Iss. 5, 2016-05 ,pp. : 529-532

Bentham Science Publishers

Access to resources Recommend Favorite

The status of pharmacotherapy for autism spectrum disorders

By Myers Scott M  

Expert Opinion on Pharmacotherapy, Vol. 8, Iss. 11, 2007-08 ,pp. : 1579-1603

Informa Healthcare

Access to resources Recommend Favorite

Autism spectrum disorders: emerging pharmacotherapy

By Bostic Jeff Q   King Bryan H  

Expert Opinion on Emerging Drugs, Vol. 10, Iss. 3, 2005-08 ,pp. : 521-536

Informa Healthcare

Access to resources Recommend Favorite